BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25934796)

  • 1. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
    Wang M; Zhang H; Heng X; Pang Q; Sun A
    Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
    Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
    Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
    Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
    Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
    Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
    Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L; Liu YS; Wang LS; Yin HG; Hou QT; Liu ZX; Chen LH; Ling F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):651-3, 666. PubMed ID: 16114549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study of p16 gene expression in pituitary adenomas].
    Yu WH; Hui GZ; Wang Q; Wu SR
    Ai Zheng; 2003 Feb; 22(2):198-201. PubMed ID: 12600300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
    Li W; Zhang Y; Zhang M; Huang G; Zhang Q
    J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin products in pituitary tumors.
    Jankowska A; Wasko R; Waligorska-Stachura J; Andrusiewicz M; Jaskula M; Liebert W; Sowinski J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):1033-7. PubMed ID: 19112393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
    Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
    Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
    Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
    Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.
    Li S; Zhang Z; Xue J; Guo X; Liang S; Liu A
    Med Sci Monit; 2015 Aug; 21():2433-8. PubMed ID: 26286316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.
    Yoshida D; Teramoto A
    Cell Adh Migr; 2007; 1(1):43-51. PubMed ID: 19262092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.
    Yu C; Li J; Sun F; Cui J; Fang H; Sui G
    Med Sci Monit; 2016 Dec; 22():5101-5108. PubMed ID: 28012286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and significance of E-cadherin and β-catenins in pituitary adenoma.
    Zhou K; Jin H; Luo Y
    Int J Surg Pathol; 2013 Aug; 21(4):363-7. PubMed ID: 23349466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of doublecortin (DCX) in pituitary adenoma.
    Liu X; Ma L; Wang Z; Ye J; Liu X; Jiang G; Wang H
    Bull Cancer; 2019 Dec; 106(12):1080-1085. PubMed ID: 31376915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
    Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.